CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 125 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $56,000 | -79.2% | 30,340 | -6.4% | 0.00% | -95.0% |
| Q4 2019 | $269,000 | +74.7% | 32,403 | +55.5% | 0.08% | +40.4% |
| Q3 2019 | $154,000 | -72.1% | 20,843 | -57.6% | 0.06% | -72.1% |
| Q2 2019 | $551,000 | -51.7% | 49,123 | -35.0% | 0.20% | -35.8% |
| Q4 2018 | $1,141,000 | -7.7% | 75,586 | +13.1% | 0.32% | +19.1% |
| Q3 2018 | $1,236,000 | +149.7% | 66,809 | +208.6% | 0.27% | +159.2% |
| Q2 2018 | $495,000 | -18.3% | 21,650 | +1.6% | 0.10% | -12.0% |
| Q1 2018 | $606,000 | -44.0% | 21,300 | -58.4% | 0.12% | -54.1% |
| Q4 2017 | $1,082,000 | +29.9% | 51,233 | +11.7% | 0.26% | +34.2% |
| Q3 2017 | $833,000 | +54.5% | 45,853 | +31.8% | 0.19% | +25.8% |
| Q2 2017 | $539,000 | – | 34,803 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |